Contact: Rex Graham
San Diego Biotechnology Connection
Caption: Cardium Therapeutics' Generx DNA-based product candidate has already been shown to be safe in clinical studies involving 650 patients at more than 100 medical centers.
Credit: ęCardium Therapeutics
Usage Restrictions: Use with photo credit
Related news release: Delivery of gene-therapy for heart disease boosted 100-fold; now in 100-patient trial